Evaluating Latest Evidence and Treatment Targets in Moderate to Severe Atopic Dermatitis

home / insights / evaluating-latest-evidence-and-treatment-targets-in-moderate-to-severe-atopic-dermatitis

Christopher Bunick, MD, PhD, discusses the management of moderate to severe atopic dermatitis, including the use of systemic treatments, the importance of patient-reported outcomes in clinical trials and patient care, and advice for clinicians on developing comprehensive treatment plans.

© 2024 MJH Life Sciences

All rights reserved.